TM6SF2 and metabolic syndrome: That this gene is also associated with disturbed cholesterol metabolism and so may modify risk of cardiovascular events including myocardial infarction20 suggests that TM6SF2 is an important determinant of clinical outcome across several facets of metabolic syndrome-related end-organ damage.